Pharma partnerships promise big advances for personalized therapies.
CLP’s February 2014 Tech Guide features products that perform clinical chemistry and immunoassay tests in a wide range of healthcare environments.
Automating the microbiology laboratory is the last frontier.
Lab adoption and applications for POC testing are continuing to expand.
Real-time automation improves utility for molecular technologies.
Scientists at the National University of Singapore have discovered a biomarker that may improve the diagnosis, prognosis, and treatment of esophageal squamous cell carcinoma, the leading cause of cancer death worldwide.
Editor-in-Chief Steve Halasey discusses next-generation sequencing with Gregory Heath, senior vice president and general manager for diagnostics at Illumina.
The State Health Information Exchange Program of the Office of the National Coordinator for Health Information Technology has issued a briefing on the importance of the exchange of clinical lab data for advancing and improving the healthcare system.
Molecular diagnostics company Biodesix announced that it has closed $8.4 million in Series E financing. The capital will help develop the company’s mass-spec technology platform and market the company’s first test, VeriStat, to guide NSCLC therapy.
Genomic Health and the Almac Group are developing a multi-gene test that could improve screening of patients eligible for anthracycline-based chemotherapy regimens, currently one of the most common treatments available.